Evidence map›Paper›PMID 26950732›Full record

ArticlePloS one2016

Proteomic Analysis of the Secretome of Cellulomonas fimi ATCC 484 and Cellulomonas flavigena ATCC 482.

Warren W Wakarchuk, Denis Brochu, Simon Foote, Anna Robotham, Hirak Saxena, Tamara Erak, John Kelly

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. A draft genome sequence ofMicrobiology resource announcements · 2025
    Article
  4. Article
  5. Inoculation of the fungi-staticFrontiers in microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Chitin-Active Lytic Polysaccharide Monooxygenases Are Rare inApplied and environmental microbiology · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Warren W WakarchukDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
Denis BrochuHuman Health Therapeutics Program, National Research Council Canada, Ottawa, Ontario, Canada.
Simon FooteHuman Health Therapeutics Program, National Research Council Canada, Ottawa, Ontario, Canada.
Anna RobothamHuman Health Therapeutics Program, National Research Council Canada, Ottawa, Ontario, Canada.
Hirak SaxenaDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
Tamara ErakDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
John KellyHuman Health Therapeutics Program, National Research Council Canada, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bacteria in the genus Cellulomonas are known for their ability to degrade plant cell wall biomass. Cellulomonas fimi ATCC 484 and C. flavigena ATCC 482 have been the subject of much research into secreted cellulases and hemicellulases. Recently the genome sequences of both C. fimi ATCC 484 and C. flavigena ATCC 482 were published, and a genome comparison has revealed their full spectrum of possible carbohydrate-active enzymes (CAZymes). Using mass spectrometry, we have compared the proteins secreted by C. fimi and C. flavigena during growth on the soluble cellulose substrate, carboxymethylcellulose (CMC), as well as a soluble xylan fraction. Many known C. fimi CAZymes were detected, which validated our analysis, as were a number of new CAZymes and other proteins that, though identified in the genome, have not previously been observed in the secretome of either organism. Our data also shows that many of these are co-expressed on growth of either CMC or xylan. This analysis provides a new perspective on Cellulomonas enzymes and provides many new CAZyme targets for characterization.

Indexed as

ProteomicsCarboxymethylcellulose SodiumCellulomonasSpecies SpecificityXylansCarboxymethylcellulose SodiumXylans

Identifiers

PMID26950732
PMCPMC4780727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.